Status:
UNKNOWN
Pilocarpine and Brimonidine in Patients With Monofocal Lenses
Lead Sponsor:
Massachusetts Eye and Ear Infirmary
Conditions:
Presbyopia
Pseudophakia
Eligibility:
All Genders
60+ years
Phase:
EARLY_PHASE1
Brief Summary
The current study aims to assess the use of pilocarpine and brimonidine to improve near visual acuity in patietns with monofocal intraocular lenses. Thirty-three subjects with be enrolled and baseline...
Detailed Description
This research study will try to find out if pilocarpine and brimonidine can help people with intraocular lens implants read without reading glasses. Thirty-three subjects will take part in this resear...
Eligibility Criteria
Inclusion
- Individuals must meet all of the inclusion criteria in order to be eligible to participate in the study. Men and women between ages 60 years and above with monofocal intraocular lenses bilaterally corrected for distance and +/- 0.5D sphere vision who need only +/- 2.5 D correction for reading. Given the age group selected only post menopausal women will be evaluated.
Exclusion
- Individuals meeting any of the exclusion criteria at baseline will be excluded from study participation including: allergies to proparacaine, pilocarpine or brimonidine, eye infection or inflammation, glaucoma, retinal tear or retinal disease, eye surgery within the past 30 days, use of eye drops within the last seven days, participated in any other research study within the past 30 days. Patients using contact lenses.
Key Trial Info
Start Date :
January 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT03825081
Start Date
January 21 2019
End Date
December 31 2019
Last Update
January 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts Eye and Ear
Boston, Massachusetts, United States, 02114